Found 13 matching trials
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
PHASE1The study is being conducted to evaluate the safety, tolerability and effic...
Location
Chinese People's Liberation Army General Hospital
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer
PHASE1The study is being conducted to evaluate the safety, tolerability and effic...
Location
Affiliated Cancer Hospital of Shandong First Medical University
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
PHASE2In phase II, the main objective is to evaluate the efficacy of SHR-A2102 co...
Location
Fudan University Shanghai Cancer Center
Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer
PHASE2Our study is aimed to evaluate the efficacy and safety of novel ADCs named ...
Location
Beijing GoBroad Hospital
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
PHASE1The study is being conducted to evaluate the safety, tolerability and effic...
Location
Sun Yat-sen University Cancer Center
A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE1This study is a multicenter, open-label, dose-finding/efficacy-expanding Ph...
Location
Shanghai Chest Hospital
A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma
PHASE3The study is being conducted to evaluate the efficacy of SHR-A2102 with ade...
Location
Beijing Cancer Hospital
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
PHASE2The study is a Phase II study to explore the efficacy and safety of SHR-A21...
Location
Guangdong Provincial People's Hospital
A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors
PHASE1The study is being conducted to evaluate the safety, tolerability and effic...
Location
Peking University Cancer Hospital
SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast Cancer
PHASE2This is a prospective, open-label, multicenter Phase II study evaluating th...
Location
Multiple Locations